New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with EffientÂ® (Prasugrel) or PlavixÂ® (Clopidogrel) Presented at TCT